SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-002907
Filing Date
2024-01-18
Accepted
2024-01-18 16:25:08
Documents
12
Period of Report
2024-01-12
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 45074
  Complete submission text file 0001493152-24-002907.txt   212240

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE atrx-20240112.xsd EX-101.SCH 3054
3 XBRL LABEL FILE atrx-20240112_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE atrx-20240112_pre.xml EX-101.PRE 22385
6 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 2984
Mailing Address P.O. BOX 2161 WAKE FOREST NC 27588
Business Address P.O. BOX 2161 WAKE FOREST NC 27588 919-578-5901
Adhera Therapeutics, Inc. (Filer) CIK: 0000737207 (see all company filings)

IRS No.: 112658569 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-13789 | Film No.: 24542147
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)